Professional Documents
Culture Documents
By
Farooq Mubarak & Abdullah Tehseen
AGENDA
History.
Attention Of Government
Crises
Current Scenario
Economic Drivers ; Growth Rate
Problems
Pricing
Import
Categories Of Medicines Produced
Steps To Ensure Quality
Conclusion
History Of Pharma Industry
In Pakistan.
During independence, Pakistan had
virtually no Pharma Industry.
1948 --1971
Crises
The year 1972 saw the introduction of Drug Generic Act which
implied discriminatory and restrictive registration policy
hampering the growth of national manufacturers who suffered a
lot and gradually lost their export market.
Local Units-----------------------386
Multinational Units------------30
Province-Wise Divison
Local Units:
Punjab------------------------- 265 units
Sindh--------------------------- 76 units
N.W.F.P------------------------ 37 units
Balochistan……………… 5 units
Azad Kashmir……………. 2 units.
Multinational Units:
Sindh----------------------------- 23 units
Punjab--------------------------- 5 units
Balochistan--------------------- 2 units
Economic Drivers
External Economic Drivers
An increase in per capita income which has provided greater disposable income for
health related expenditures.
It is also said in the report that nearly 1,7500 people die each
year in Pakistan due to these substandard medicines.
The other key reason for high prices is the partial deregulation policy
undertaken by the government in the year 1993 which raised the prices
of drugs by nearly 400% in just few months.
Some of the irrational drugs that have been banned in the West are still
sold in Pakistan. Local doctors are misled by the pharmaceutical
companies to prescribe unethical formulations and the government
remains silent and allows this to go on so as not to offend the WTO and
the icon of "free trade".
Actions Taken By Governement To
Ensure Quality
The federal health secretary Ejaz Rahim has recently announced in a
press conference at Karachi that Pakistan Health Ministry is
considering making a committee comprising of the World Health
Organisation (WHO), Pakistan Pharmaceutical Manufacturers
Association and Health Ministry to keep check on the quality of drugs
available in the market.
This industry needs more attention of the government regarding health standards
and quality standards of the product. Almost every medicine’s catalouge should
mention the “adverse affects” clearly. The workers employed at packing, unpacking
of the medicines and those who are physically related with the production of certain
medicines should be treated with certain health measures.
Questions?